2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)

被引:0
|
作者
S Yokota
T Imagawa
T Miyamae
K Kasai
M Mori
N Nishimoto
T Kishimoto
机构
[1] Yokohama City University,
[2] Osaka University,undefined
关键词
Corticosteroid; Respiratory Tract Infection; Juvenile Idiopathic Arthritis; Gastroenteritis; Tocilizumab;
D O I
10.1186/1546-0096-6-S1-S1
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Efficacy and safety of abatacept for systemic juvenile idiopathic arthritis: A systematic review
    Nishimura, Kenichi
    Ishikawa, Takashi
    Okamoto, Nami
    Akamine, Keiji
    Inoue, Natsumi
    Irabu, Hitoshi
    Kato, Kentaro
    Keino, Hiroshi
    Kojima, Masayo
    Kubo, Hiroshi
    Maruyama, Kazuichi
    Mizuta, Mao
    Shabana, Kosuke
    Shimizu, Masaki
    Sugita, Yuko
    Takakuwa, Yukiko
    Takanashi, Satoshi
    Takase, Hiroshi
    Umebayashi, Hiroaki
    Umezawa, Natsuka
    Yamanishi, Shingo
    Yamazaki, Kazuko
    Yashiro, Masato
    Yasumi, Takahiro
    Mori, Masaaki
    MODERN RHEUMATOLOGY, 2024, 35 (01) : 167 - 173
  • [32] Low prevalence of subclinical synovitis in patients with juvenile idiopathic arthritis (JIA) in long-term clinical remission on medication
    Claudia Loredo
    Patricia Yañez
    Cristina Hernández-Díaz
    Esteban Cruz-Arenas
    Lucio Ventura-Ríos
    Clinical Rheumatology, 2024, 43 : 393 - 398
  • [33] Long-term follow-up of systemic onset juvenile idiopathic arthritis patients treated with Anakinra
    Marco Gattorno
    Aldo Naselli
    Andrea Accogli
    Sabrina Chiesa
    Roberta Caorsi
    Jessica Tebaldi
    Antonella Buoncompagni
    Nicola Ruperto
    Stefania Viola
    Paolo Picco
    Angelo Ravelli
    Alberto Martini
    Pediatric Rheumatology, 9 (Suppl 1)
  • [34] Low prevalence of subclinical synovitis in patients with juvenile idiopathic arthritis (JIA) in long-term clinical remission on medication
    Loredo, Claudia
    Yanez, Patricia
    Hernandez-Diaz, Cristina
    Cruz-Arenas, Esteban
    Ventura-Rios, Lucio
    CLINICAL RHEUMATOLOGY, 2024, 43 (01) : 393 - 398
  • [35] Sport and exercise habits in children with juvenile idiopathic arthritis (JIA)
    M Nørgaard
    T Herlin
    Pediatric Rheumatology, 9 (Suppl 1)
  • [36] New insights and long-term safety of tocilizumab in rheumatoid arthritis
    Jones, Graeme
    Panova, Elena
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (10) : 195 - 199
  • [37] Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years
    Farah, Ziad
    Ali, Sabreen
    Price-Kuehne, Fiona
    Mackworth-Young, Charles G.
    BIOLOGICS-TARGETS & THERAPY, 2016, 10 : 59 - 66
  • [38] Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis
    Ayush Gupta
    Narendra Kumar Bagri
    Saroj Kumar Tripathy
    Adarsh Barwad
    Ravi Hari Phulware
    Pankaj Hari
    Rheumatology International, 2020, 40 : 153 - 159
  • [39] Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis
    Gupta, Ayush
    Bagri, Narendra Kumar
    Tripathy, Saroj Kumar
    Barwad, Adarsh
    Phulware, Ravi Hari
    Hari, Pankaj
    RHEUMATOLOGY INTERNATIONAL, 2020, 40 (01) : 153 - 159
  • [40] The use of tocilizumab in a child with systemic onset juvenile idiopathic arthritis and ganglioneuroblastoma
    Ristic Goran
    Djokic Dragutin
    Pasic Srdjan
    Pediatric Rheumatology, 9 (Suppl 1)